University of Sydney
MPRU
 
 


Psychosocial predictors of the development and outcome of cancer


The role of psychosocial factors in developing cancer in women from high risk breast cancer families
This is a 10 year cohort study of 2,500 women currently unaffected by cancer who are participating in the Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab). Participants complete questionnaires and a telephone interview targeting a history of stressful life events at three yearly intervals. This is the largest and best designed study exploring this question internationally to date. We aim to:

i)    Prospectively examine the role of life event stress, social support, psychological distress (anxiety, depression and medically-unexplained fatigue) and personality characteristics (optimism, anti-emotionality and controlled anger) in the development of primary breast cancer;
ii)    Describe unaffected women’s uptake of cancer screening and prophylactic surgery;
iii)    Identify predictors of the long term psychological outcomes of prophylactic surgery (e.g. body image, sexuality, breast cancer anxiety and subjective cancer risk estimates) and documents the ongoing impact
iv)    Explore the role of 5-HTT (a serotonin transporter) as a moderator of the effect of stressful life events on depression.

Funding: NHMRC


Psychosocial predictors of outcome, unmet needs and quality of life in women with ovarian cancer and their partners

This study is conducted in collaboration with the Australian Ovarian Cancer Study (AOCS). AOCS has recruited approximately 1,500 new primary epithelial ovarian cancer patients from major treatment centres in Australia during 2002-2006, collecting data on demographic and disease prognostic factors that can be shared with the Psychosocial Study. The current study aims to:

i)   Determine levels of psychological distress, social support, coping style (optimism, minimisation, helpless/hopelessness), unmet needs and quality of life in ovarian cancer patients       and their partners/primary carers, measured at 3-6 monthly intervals for 2 years;
ii)   Examine the interaction between patient and partner psychosocial variables
iii)  Prospectively investigate the role of psychological distress, social support, coping style and unmet needs in determining the outcome of ovarian cancer, in terms of a) quality of          life and b) recurrence and c) survival.

Ultimately, the aim is to develop interventions targeting the needs of ovarian cancer patients and their partners/carers.

Funding: Multi-state Cancer Research Grant


Predicting bereavement outcomes in caregivers of women with ovarian cancer
Recent evidence suggests that caregivers are at significantly greater risk of getting sick or dying after the death of their spouse or family member. This may be especially true for caregivers who are experiencing a difficult and prolonged bereavement, with some evidence to suggest that those experiencing complicated grief have an increased risk of poorer long term physical and mental health outcomes. This prospective study follows up carers participating in the AOCS Quality of Life study once the woman has died, investigating pre-bereavement and end of life variables in the longer term. The aims of the study include:

i)    Determine the prevalence of complicated grief and establish the physical and psychological impact of bereavement in caregivers;
ii)   Evaluate caregivers’ access to and utilisation of palliative care services;
iii)  Prospectively investigate the role of pre-bereavement, circumstances surrounding the end of life, and grief, in determining the physical and psychological health outcomes; and
iv)  Qualitatively explore the caregivers’ concept of ‘a good death’ and ‘a good bereavement’ and the determinants of a good bereavement.

The results of this study have the potential to assist early identification of those at risk of poorer health outcomes, and provide evidence for the design of targeted interventions that may impact directly on service provision and health costs.

Funding: University of Sydney Cancer Research Fund


[ Back to Current Research Projects ]